Sean Hui
Overview
Explore the profile of Sean Hui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hui S, Zeid K, Kou R, Mallick R, Carrier M, Wang T
J Thromb Haemost
. 2024 Oct;
23(1):201-209.
PMID: 39401736
Background: Tumor thrombus can be associated with an increased risk of venous thromboembolism (VTE) and poor prognosis. The risks and benefits of anticoagulation remain unclear. Objectives: To evaluate the role...
2.
Donnellan F, Rayaprolu V, Rijal P, ODowd V, Parvate A, Callaway H, et al.
bioRxiv
. 2024 Jul;
PMID: 38979279
Ebolavirus disease (EVD) is caused by multiple species of . Monoclonal antibodies (mAbs) against the virus glycoprotein (GP) are the only class of therapeutic approved for treatment of EVD caused...
3.
Adler S, Mattice A, Eagles D, Yadav K, Hui S, Azward A, et al.
CJEM
. 2024 Mar;
26(5):327-332.
PMID: 38530599
Objectives: Acute atrial fibrillation (AF)/flutter (AFL) is a common emergency department (ED) presentation. In 2021, an updated version of CAEP's Acute AF/AFL Best Practices Checklist was published, seeking to guide...
4.
Mattice A, Adler S, Eagles D, Yadav K, Hui S, Azward A, et al.
CJEM
. 2024 Mar;
26(5):333-338.
PMID: 38519830
Objectives: Acute atrial fibrillation and flutter (AF/AFL) are common arrhythmias treated in the emergency department (ED). The 2021 CAEP Best Practices Checklist provides clear recommendations for management of patients with...
5.
Sale J, Frankel L, Bogoch E, Carlin-Coleman G, Hui S, Saini J, et al.
BMC Geriatr
. 2024 Feb;
24(1):180.
PMID: 38388900
Background: There has been little exploration of the effect of fragility fractures on patient perceptions of their age. The common assumption is that fractures "happen to old people". In individuals...
6.
Yu X, Hastie K, Davis C, Avalos R, Williams D, Parekh D, et al.
Cell Rep
. 2023 Nov;
42(11):113366.
PMID: 37938974
Monoclonal antibodies against the Ebola virus (EBOV) surface glycoprotein are effective treatments for EBOV disease. Antibodies targeting the EBOV glycoprotein (GP) head epitope have potent neutralization and Fc effector function...
7.
Rayaprolu V, Fulton B, Rafique A, Arturo E, Williams D, Hariharan C, et al.
Cell Host Microbe
. 2023 Jan;
31(2):260-272.e7.
PMID: 36708708
Monoclonal antibodies can provide important pre- or post-exposure protection against infectious disease for those not yet vaccinated or in individuals that fail to mount a protective immune response after vaccination....
8.
Callaway H, Hastie K, Schendel S, Li H, Yu X, Shek J, et al.
Cell Rep
. 2023 Jan;
42(1):112014.
PMID: 36681898
The SARS-CoV-2 Omicron variant of concern (VoC) and its sublineages contain 31-36 mutations in spike and escape neutralization by most therapeutic antibodies. In a pseudovirus neutralization assay, 66 of the...
9.
Peng W, Rayaprolu V, Parvate A, Pronker M, Hui S, Parekh D, et al.
Commun Biol
. 2022 Aug;
5(1):785.
PMID: 35927436
The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response. GP is heavily glycosylated with up to 17...
10.
Milligan J, Davis C, Yu X, Ilinykh P, Huang K, Halfmann P, et al.
Cell
. 2022 Mar;
185(6):995-1007.e18.
PMID: 35303429
Several ebolaviruses cause outbreaks of severe disease. Vaccines and monoclonal antibody cocktails are available to treat Ebola virus (EBOV) infections, but not Sudan virus (SUDV) or other ebolaviruses. Current cocktails...